17056915

Source:http://linkedlifedata.com/resource/pubmed/id/17056915

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0041618, umls-concept:C0150369, umls-concept:C0238198, umls-concept:C0332293, umls-concept:C0871261, umls-concept:C0935989, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	5
pubmed:dateCreated	2006-10-23
pubmed:abstractText	The purpose of this study was to evaluate contrast-enhanced Doppler sonography with perfusion software as a predictor of early tumor response to imatinib (Glivec) in c-kit-positive gastrointestinal stromal tumors (GISTs).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7708173
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Contrast Media, http://linkedlifedata.com/resource/pubmed/chemical/Phospholipids, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Polysaccharides, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-kit, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/SHU 508, http://linkedlifedata.com/resource/pubmed/chemical/Sulfur Hexafluoride, http://linkedlifedata.com/resource/pubmed/chemical/contrast agent BR1, http://linkedlifedata.com/resource/pubmed/chemical/imatinib
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1546-3141
pubmed:author	pubmed-author:BonvalotSylvieS, pubmed-author:ChamiLindaL, pubmed-author:LamuragliaMicheleM, pubmed-author:LassauNathalieN, pubmed-author:Le CesneAxelA, pubmed-author:LeclèreJeromeJ, pubmed-author:RocheAlainA, pubmed-author:TerrierPhilippeP
pubmed:issnType	Electronic
pubmed:volume	187
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1267-73
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:17056915-Antineoplastic Agents, pubmed-meshheading:17056915-Contrast Media, pubmed-meshheading:17056915-Female, pubmed-meshheading:17056915-Gastrointestinal Stromal Tumors, pubmed-meshheading:17056915-Humans, pubmed-meshheading:17056915-Liver Neoplasms, pubmed-meshheading:17056915-Male, pubmed-meshheading:17056915-Middle Aged, pubmed-meshheading:17056915-Neoplasm Recurrence, Local, pubmed-meshheading:17056915-Phospholipids, pubmed-meshheading:17056915-Piperazines, pubmed-meshheading:17056915-Polysaccharides, pubmed-meshheading:17056915-Prognosis, pubmed-meshheading:17056915-Protein Kinase Inhibitors, pubmed-meshheading:17056915-Protein-Tyrosine Kinases, pubmed-meshheading:17056915-Proto-Oncogene Proteins c-kit, pubmed-meshheading:17056915-Pyrimidines, pubmed-meshheading:17056915-Sulfur Hexafluoride, pubmed-meshheading:17056915-Ultrasonography, Doppler
pubmed:year	2006
pubmed:articleTitle	Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography.
pubmed:affiliation	Department of Medical Imaging, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France. lassau@igr.fr
pubmed:publicationType	Journal Article, Clinical Trial